Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vancomycin-induced neutropenia.

R L Mackett, D R Guay

    Canadian Medical Association Journal
    |January 1, 1985
    PubMed
    Summary

    Long-term vancomycin therapy can cause neutropenia, a rare side effect. Monitoring white blood cell counts is recommended during vancomycin treatment to detect this potential complication.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Review of cefditoren, an advanced-generation, broad-spectrum oral cephalosporin.

    Clinical therapeutics·2002
    Same author

    Adjunctive agents in the management of chronic pain.

    Pharmacotherapy·2001
    Same author

    Pet-assisted therapy in the nursing home setting: potential for zoonosis.

    American journal of infection control·2001
    Same author

    Pharmacokinetics and tolerability of extended-release clarithromycin.

    Clinical therapeutics·2001
    Same author

    An update on the role of nitrofurans in the management of urinary tract infections.

    Drugs·2001
    Same author

    Pharmacodynamics and pharmacokinetics of cefdinir, an oral extended spectrum cephalosporin.

    The Pediatric infectious disease journal·2001

    Area of Science:

    • Pharmacology
    • Hematology
    • Infectious Diseases

    Background:

    • Vancomycin is a critical antibiotic for treating serious Gram-positive bacterial infections, including Staphylococcus aureus.
    • Neutropenia, a decrease in neutrophils, is a potential adverse effect of certain medications.
    • This case highlights a rare but significant adverse event associated with vancomycin use.

    Observation:

    • A 67-year-old female patient with cellulitis and sepsis due to Staphylococcus aureus developed neutropenia.
    • The patient was initially treated with cefazolin, but due to persistent fever, therapy was switched to vancomycin.
    • Neutropenia was observed on day 17 of vancomycin therapy and worsened over the subsequent three days.

    Findings:

    • Discontinuation of vancomycin led to a rapid recovery of neutrophil count within five days.
    • This case demonstrates a direct correlation between vancomycin administration and the onset of neutropenia.
    • The patient's neutrophil count normalized after cessation of the antibiotic.

    Implications:

    • Periodic monitoring of leukocyte counts is crucial for patients on long-term vancomycin therapy.
    • Early detection and discontinuation of vancomycin can prevent severe neutropenia and its complications.
    • This finding underscores the importance of vigilant patient monitoring for adverse drug reactions during antibiotic treatment.

    Related Experiment Videos